Atricure (ATRC)
NASDAQ:ATRC
Want to see ATRC full AI Analyst Report?
Earnings Data
Report Date
Aug 04, 2026After Close (Confirmed)
Period Ending
2026 (Q2)Consensus EPS Forecast
>-0.01Last Year’s EPS
-0.13Same Quarter Last Year
Strong Buy
Based on 9 Analysts Ratings
Earnings Call Summary
Earnings Call Sentiment|Positive
The call emphasized durable double-digit revenue growth, meaningful margin expansion, near-term profitability improvement (adjusted EBITDA and net income turning positive), strong U.S. product adoption (notably pain management, EnCompass and AtriClip FLEX-Mini), and materially accelerated enrollment in the BoxX-NoAF trial — all significant positives. Offsetting items include a steep decline in MIS ablation, international softness (U.K. and Asia distributor lumpiness), incremental R&D and SG&A to support accelerated trials and launches, and a manufacturing ramp that will moderate gross margin improvement. On balance, the positives (strong top-line, EBITDA expansion, cash position, and trial momentum) outweigh the negatives, which are mostly transient or strategic investments.Company Guidance
Top-Line Growth
Worldwide revenue of $141.2M in Q1 2026, up 14.3% reported and 12.8% constant currency vs Q1 2025; sequential increase ~1% vs Q4 2025.
U.S. Performance Driving Momentum
U.S. revenue $116.2M, up 14.9% YoY; strength led by new-product adoption across pain management, open ablation and appendage management.
Improved Profitability and EBITDA Expansion
Adjusted EBITDA of $17.1M vs $8.8M in Q1 2025, a 95% increase; net income ~ $0.1M vs net loss $6.7M prior year; EPS breakeven at $0.00 vs loss per share $0.14 in Q1 2025.
Strong Gross Margin Expansion
Gross margin of 77.4%, up 246 basis points year-over-year driven by favorable product and geographic mix and strong U.S. performance.
Pain Management Franchise Acceleration
Pain management grew 28% YoY; cryoSPHERE MAX drove growth, contributing ~70% of pain management sales in the quarter and ~70% adoption within pain accounts.
Appendage Management Growth and Product Adoption
Appendage management grew 16% worldwide; U.S. open appendage revenue $48.4M (+14.9% YoY) with AtriClip FLEX-Mini contributing ~40% of open appendage revenue and continued share gains.
Open Ablation Strength (EnCompass)
Worldwide open ablation revenue grew 15% YoY; U.S. open ablation sales up 17.3% to $39.1M driven by EnCompass clamp adoption in U.S. and Europe.
BoxX-NoAF Trial Enrollment Progress
Enrolled ~300 of planned 960 patients since Q4 2025; tracking well ahead of schedule and expecting enrollment completion around year-end (nearly a year ahead of original plan), supporting potential landmark clinical evidence.
Balance Sheet and Cash Outlook
Ended Q1 with ~$146M in cash and investments; cash burn improved vs prior year and company expects positive cash flow for remainder of 2026 with full-year cash generation moderately higher than 2025.
Reiterated 2026 Guidance
Maintained full-year revenue outlook of $600M–$610M (≈12%–14% growth), adjusted EBITDA guidance of $80M–$82M, and full-year adjusted EPS guidance of $0.09–$0.15.
ATRC Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
ATRC Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
May 05, 2026 | $29.39 | $28.01 | -4.70% |
Feb 17, 2026 | $32.97 | $32.26 | -2.15% |
Oct 29, 2025 | $35.44 | $34.09 | -3.81% |
Jul 29, 2025 | $31.73 | $35.13 | +10.72% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Atricure (ATRC) report earnings?
Atricure (ATRC) is schdueled to report earning on Aug 04, 2026, After Close (Confirmed).
What is Atricure (ATRC) earnings time?
Atricure (ATRC) earnings time is at Aug 04, 2026, After Close (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is ATRC EPS forecast?
ATRC EPS forecast for the fiscal quarter 2026 (Q2) is >-0.01.